Sign In
Buy NAUT
$2.58
-0.100 (-3.73%)
At Close: Jun 03, 2026
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results
08:00am, Wednesday, 28'th Feb 2024
SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial r
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference
08:00am, Thursday, 22'nd Feb 2024
SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
08:00am, Wednesday, 07'th Feb 2024
SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will rep
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award
08:00am, Thursday, 30'th Nov 2023
Society award recognizes Dr. Mallick's decades of innovative leadership and science advancing the field of computational proteomics Society award recognizes Dr. Mallick's decades of innovative leaders
Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development
08:05am, Wednesday, 01'st Nov 2023
Former Quantapore founder and CEO brings 20 years of proteomics and genomics industry experience to company developing a platform for comprehensively quantifying the proteome Former Quantapore founder
Nautilus Biotechnology, Inc. (NAUT) Q3 2023 Earnings Call Transcript
11:22am, Tuesday, 31'st Oct 2023
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q3 2023 Earnings Conference Call October 31, 2023 8:30 AM ET Company Participants Carrie Mendivil - IR Sujal Patel - Co-Founder & CEO Parag Mallick - Co-Fou
Nautilus Biotechnology Reports Third Quarter 2023 Financial Results
08:05am, Tuesday, 31'st Oct 2023
SEATTLE, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial r
Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
08:05am, Wednesday, 11'th Oct 2023
SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will rep
Nautilus Biotechnology to Participate in Upcoming August Investor Conferences
08:00am, Friday, 04'th Aug 2023
SEATTLE, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company
Nautilus Biotechnology, Inc. (NAUT) Q2 2023 Earnings Call Transcript
01:33pm, Wednesday, 02'nd Aug 2023
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q2 2023 Earnings Conference Call August 2, 2023 8:30 AM ET Company Participants Carrie Mendivil - Investor Relations Sujal Patel - Co-Founder, Chief Executi
Nautilus Biotechnology Reports Second Quarter 2023 Financial Results
07:30am, Wednesday, 02'nd Aug 2023
SEATTLE, Wash., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported fina
Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023
09:23am, Tuesday, 11'th Jul 2023
SEATTLE, July 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will rep
Nautilus Biotechnology to Participate in Upcoming June Investor Conferences
08:05am, Wednesday, 24'th May 2023
SEATTLE, May 24, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company
Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023
04:05pm, Tuesday, 18'th Apr 2023
SEATTLE, April 18, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will re
Nautilus Biotechnology to Participate in B. Riley Securities' Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference
08:00am, Thursday, 23'rd Mar 2023
SEATTLE, March 23, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the compan
